Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 33 AND POTASSIUM CHLORIDE 0 30 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 33 AND POTASSIUM CHLORIDE 0 30 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER.
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.30% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides a source of calories and serves as a metabolic substrate; sodium chloride and potassium chloride replace electrolytes and maintain acid-base balance and osmotic pressure.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Intravenous infusion; dose determined by fluid, electrolyte, and caloric requirements. Typical adult maintenance: 100-125 mL/hour; potassium not to exceed 10 mEq/hour or 200 mEq/day.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
None Documented
None Documented
Dextrose: not applicable (endogenous substance, rapidly cleared from blood; half-life of infused glucose is ~15-20 min due to cellular uptake and metabolism). Potassium: not applicable as a drug; serum potassium half-life depends on redistribution and renal function (typically ~8-12 h for a load). Sodium: no defined half-life; renal regulation maintains homeostasis.
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Dextrose: metabolized to CO2 and water; negligible renal excretion. Sodium and potassium: primarily renal excretion (90-95% of filtered load reabsorbed; excretion adjusts to intake and balance). Chloride: renal excretion, passively follows sodium. No biliary or fecal elimination of significance.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Category A/B
Category C
Electrolyte
Electrolyte